Posters
Real-World Evidence Demonstrating the Clinical Performance and Utility of the Labcorp® Plasma Focus™ Liquid Biopsy Test
17 Nov 2023
The Labcorp Plasma Focus test demonstrated a 95.8% success rate and was able to detect clinically actionable variants across various cancer types, with rapid reporting for the majority of cases, highlighting its effectiveness in informing precision oncology decision-making.
- Ellen L. Verner
- Jennifer B. Jackson
- Ronald Przygodzki
- Mark Sausen
- Eric A. Severson
- Brian Caveney
- Marcia Eisenberg
- Taylor J. Jensen
- Shakti Ramkissoon